UF BME Welcomes Two New Industry Partners

The J. Crayton Pruitt Family Department of Biomedical Engineering is pleased to announce its two newest members to the Industry Partners Program: BioD, LLC and Exactech.

Both of our new partners are eager to bridge strategic collaborations and new partnerships between our fast-growing BME program and that of their respective companies.

BioD, LLC is a vertically integrated biotechnology company engaged in the development and commercialization of novel biologic products derived from the placental tissues. Their research and development efforts are focused on the regenerative potential of amnion and the other placental tissues given their unique biologic structure, their rich source of undifferentiated stem cells, and the unique immune privilege that characterizes their function in the body. From the recovery of tissue from live, healthy donors during childbirth to the development of new products that improve patient outcomes, BioD is unlocking the regenerative potential of the human body.

Exactech develops and markets orthopaedic implant devices, related surgical instruments and biologic materials and services to hospitals and physicians. The company manufactures many of its orthopaedic devices at its Gainesville facility. Exactech’s orthopaedic products are used in the restoration of bones and joints that have deteriorated as a result of injury or diseases such as arthritis. Exactech markets its products in the United States, in addition to more than 30 markets in Europe, Latin America, Asia and the Pacific.

The goal for our new BME Industry Partners Program is to share knowledge and ideas, and to engage in research and educational collaborations with our Industry Partners in pursuit of solutions that will help advance patient outcomes and train the next generation of engineers. Together, we can become a much more influential force in helping to move the discoveries of today into the solutions of tomorrow.

Exactech and BioD, LLC will join our four existing Industry Partners:

Alafair Biosciences develops cross-linked polysaccharide hydrogel films to address the post-surgical complication of unwanted soft tissue attachments, or tethering between opposing tissue surfaces. Alafair Biosciences is a privately held early stage life sciences company based in Austin, Texas. Alafair is funded by private financial investment and public research grants. Their initial technology, licensed and developed with The University of Texas at Austin, is a hydrogel membrane that provides support during post-surgical critical wound healing.

AxoGen, Inc. is a regenerative medicine company focused on the science, development and commercialization of technologies for peripheral nerve regeneration and reconstruction to help patients suffering from traumatic injuries or undergoing surgeries that impact the function of their peripheral nerves. AxoGen provides surgeons with solutions to repair and protect peripheral nerves. The company has created and licensed a unique combination of patented nerve repair technologies to change the standard of care for patients with peripheral nerve injuries.

RTI Surgical is a leading global surgical implant company providing surgeons with safe biologic, metal and synthetic implants. Committed to delivering a higher standard, RTI’s implants are used in sports medicine, general surgery, spine, orthopedic, trauma and cardiothoracic procedures and are distributed in nearly 50 countries. RTI is headquartered in Alachua, Fla., and has four manufacturing facilities throughout the U.S. and Europe.  RTI is accredited in the U.S. by the American Association of Tissue Banks and is a member of AdvaMed.

Stryker Sustainability Solutions is the leading provider of reprocessing and remanufacturing services for medical devices as well as comprehensive recycling and redistribution initiatives. Stryker was the first global Original Manufacturer (OM) to offer innovative, cost-effective programs, such as reprocessing and remanufacturing, to help meet the resource management demands of its hospital partners. Stryker’s programs specifically target inefficient practices and reclaim and redirect consumable and financial resources in order to promote healthy and responsible hospitals.

If your company or organization would like more information on how to become a BME Industry Partner, or would like more information, please visit our Industry Partner website at www.bme.ufl.edu/industry, or you may contact Mike Masem at 352-392-6795 or mmasem@eng.ufl.edu.

Leave a Reply